Trial Outcomes & Findings for Clinical Evaluation of Approved and Investigational Contact Lenses (NCT NCT02669095)
NCT ID: NCT02669095
Last Updated: 2017-06-09
Results Overview
Lens fit was assessed and recorded for each subject and eye at post lens fitting, 1-, 2-, 3- and 4- week follow-up evaluations. Lens fit was a binary response acceptable and unacceptable lens fit. The proportion of eyes with acceptable lens fitting at post lens fit and across all four follow-ups was combined and reported.
COMPLETED
NA
150 participants
Up to 4 Week Follow-up
2017-06-09
Participant Flow
A total of 150 subjects were enrolled in this study. All subjects enrolled into the study were dispensed a study lens. Of the dispensed subjects 146 completed the study and 4 subjects were discontinued.
Participant milestones
| Measure |
Senofilcon C
Subjects that were randomized to receive the senofilcon C lens throughout the entire duration of the study.
|
Comfilcon A
Subjects that were randomized to receive the comfilcon A lens throughout the entire duration of the study.
|
|---|---|---|
|
Overall Study
STARTED
|
75
|
75
|
|
Overall Study
COMPLETED
|
74
|
72
|
|
Overall Study
NOT COMPLETED
|
1
|
3
|
Reasons for withdrawal
| Measure |
Senofilcon C
Subjects that were randomized to receive the senofilcon C lens throughout the entire duration of the study.
|
Comfilcon A
Subjects that were randomized to receive the comfilcon A lens throughout the entire duration of the study.
|
|---|---|---|
|
Overall Study
Adverse Event
|
1
|
0
|
|
Overall Study
Unsatisfactory Lens Fitting
|
0
|
1
|
|
Overall Study
Torn Lens
|
0
|
1
|
|
Overall Study
Visit 5 assessments not completed
|
0
|
1
|
Baseline Characteristics
Clinical Evaluation of Approved and Investigational Contact Lenses
Baseline characteristics by cohort
| Measure |
Senofilcon C
n=75 Participants
Subjects that were randomized to receive the senofilcon C lens throughout the entire duration of the study.
|
Comfilcon A
n=75 Participants
Subjects that were randomized to receive the comfilcon A lens throughout the entire duration of the study.
|
Total
n=150 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
28.2 Years
STANDARD_DEVIATION 6.05 • n=5 Participants
|
30.2 Years
STANDARD_DEVIATION 5.62 • n=7 Participants
|
29.2 Years
STANDARD_DEVIATION 5.91 • n=5 Participants
|
|
Sex: Female, Male
Female
|
55 Participants
n=5 Participants
|
61 Participants
n=7 Participants
|
116 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
20 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
34 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian
|
2 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
12 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
19 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
White
|
61 Participants
n=5 Participants
|
65 Participants
n=7 Participants
|
126 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Other
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Region of Enrollment
North America
|
75 Participants
n=5 Participants
|
75 Participants
n=7 Participants
|
150 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Up to 4 Week Follow-upPopulation: Subjects that completed all study visits without a major protocol deviation.
Lens fit was assessed and recorded for each subject and eye at post lens fitting, 1-, 2-, 3- and 4- week follow-up evaluations. Lens fit was a binary response acceptable and unacceptable lens fit. The proportion of eyes with acceptable lens fitting at post lens fit and across all four follow-ups was combined and reported.
Outcome measures
| Measure |
Senofilcon C
n=740 Subject Eyes
Subjects that were randomized to receive the senofilcon C lens throughout the entire duration of the study.
|
Comfilcon A
n=720 Subject Eyes
Subjects that were randomized to receive the comfilcon A lens throughout the entire duration of the study.
|
|---|---|---|
|
Acceptable Lens Fitting
|
1 Proportion of eyes
|
0.99 Proportion of eyes
|
PRIMARY outcome
Timeframe: Up to 4 Week Follow-upPopulation: Subjects that completed all study visits without a major protocol deviation.
Clue comfort was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. CLUE Comfort was assessed at 1-, 2-, 3 and 4- week Follow-up evaluations. The average CLUE comfort score for each lens was reported for each visit.
Outcome measures
| Measure |
Senofilcon C
n=74 Participants
Subjects that were randomized to receive the senofilcon C lens throughout the entire duration of the study.
|
Comfilcon A
n=72 Participants
Subjects that were randomized to receive the comfilcon A lens throughout the entire duration of the study.
|
|---|---|---|
|
Overall Comfort
1-Week Follow-up
|
71.75 Units on a scale
Standard Deviation 22.193
|
56.68 Units on a scale
Standard Deviation 27.747
|
|
Overall Comfort
2-Week Follow-up
|
70.58 Units on a scale
Standard Deviation 22.500
|
54.69 Units on a scale
Standard Deviation 30.268
|
|
Overall Comfort
3-Week Follow-up
|
68.75 Units on a scale
Standard Deviation 26.108
|
53.43 Units on a scale
Standard Deviation 29.912
|
|
Overall Comfort
4-Week Follow-up
|
68.25 Units on a scale
Standard Deviation 27.137
|
54.57 Units on a scale
Standard Deviation 30.522
|
Adverse Events
Senofilcon C
Comfilcon A
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Kristy Canavan, O.D., FAAO Principal Research Optometrist
Johnson & Johnson Vision Care Inc.
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: GT60